The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems to help fight tumors. Research reported recently in the journal Nature ...

Researchers found that lung and skin cancer patients who got COVID-19 vaccines reported significantly increased survival ...

A stunning new study offers early evidence that Covid-19 vaccines might have a secret superpower: a precisely timed mRNA shot ...

Pfizer has axed 11 programs, including two pipeline assets from its $43 billion Seagen acquisition, work on a ...

Scientists have developed an experimental mRNA vaccine that, when combined with existing immunotherapy drugs, could 'teach' ...

University of Florida Health writer Michelle Jaffee reports a bold finding: cancer patients who got a COVID-19 mRNA vaccine within 100 days of starting immunotherapy lived longer than those who didn’t ...

CoV-2, has led to the first approval of mRNA vaccines in humans. By producing the full-length SARS-CoV-2 Spike protein, they ...